A detailed study of a SARS-Cov-2 protein, Nsp1, with a central role in weakening the host anti-viral immune response shows that it effectively shuts down production of proteins in the host. Although SARS-Cov-2 features additional inhibitors of host innate immune defenses, targeting the interaction of this protein, Nsp1, with the host may be an important therapeutic strategy, the authors say.
A major virulence factor of SARS-CoVs, including the SARS-CoV-2 virus causing the current COVID-19 pandemic, is the protein Nsp1. Upon infection, it suppresses protein production in the host ,including production of proteins active in cellular anti-viral defense mechanisms, by binding to the cell's protein production machinery, the ribosome. Targeting the pocket on the ribosome that Nsp1 binds to could be an important potential therapeutic strategy.
The authors set out to structurally characterize the Nsp1 of SARS-CoV-2 bound to the ribosome. As part of their approach, they tested the ability of a mutant form of Nsp1, known as mt-Nsp1, to affect protein production related to host immune response, in both in vitro and in vivo experiments.
The mutant version did not bind in the same way, the authors showed, and did not shut down host translation (or protein production). Through further experiments, the authors' results demonstrate that SARS-CoV-2 Nsp1 almost completely prevents production of various immune molecules that fight viral infection, including interferons.
"Our data establish that one of the major immune evasion factors of SARS-CoV-2, Nsp1, efficiently interferes with the cellular translation machinery resulting in a shut-down of host protein production," the authors write.
Even while noting that important questions remain to be addressed in this space, they say their data may provide a starting point for rational structure-based drug design targeting the interaction between Nsp1 and the ribosome.
https://science.sciencemag.org/content/early/2020/07/16/science.abc8665
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fstructural-basis-for_7&filter=22
Protein translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2
- 1,358 views
- Added
Edited
Latest News
Human skeletal muscle aging…
By newseditor
Posted 13 May
Disruption of organellar co…
By newseditor
Posted 13 May
Functional heterogeneity of…
By newseditor
Posted 13 May
Gut bacteria produced compo…
By newseditor
Posted 13 May
Role of ECM in brain memory
By newseditor
Posted 13 May
Other Top Stories
RNA editing and cancer
Read more
Modulating miRNA's to control tumorigeneis
Read more
A mutated gene found in families with multiple tumors, including ca…
Read more
Long noncoding RNA, HOTAIR promotes prostate cancer
Read more
Molecular mechanism of chemokine receptor mediated hapatic cancer
Read more
Protocols
Mime-seq 2.0: a method to s…
By newseditor
Posted 13 May
Improved detection of DNA r…
By newseditor
Posted 09 May
Single-cell adhesive profil…
By newseditor
Posted 07 May
Parasympathetic neurons der…
By newseditor
Posted 07 May
Non-invasive measurements o…
By newseditor
Posted 05 May
Publications
Human skeletal muscle aging…
By newseditor
Posted 13 May
Accumulation of APP C-termi…
By newseditor
Posted 13 May
Pharmacological induction o…
By newseditor
Posted 13 May
The Effect of Glycine and N…
By newseditor
Posted 13 May
Diindoles produced from com…
By newseditor
Posted 13 May
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar